Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
2023-05-26 Purchase | 2023-05-30 4:05 pm | NEXGEL INC. | NXGL | ZELDIS JEROME B Director | 5,000 | $2.3377 | $11,689 | 93,028 (Direct) | View |
2022-03-25 Purchase | 2022-03-28 4:07 pm | NEXGEL INC. | NXGL | ZELDIS JEROME B Director | 5,300 | $1.8887 | $10,010 | 88,028 (Direct) | View |
2021-12-27 Purchase | 2022-01-03 4:46 pm | NEXGEL INC. | NXGL | ZELDIS JEROME B Director | 9,091 | $5.49 | $49,910 | 91,819 (Direct) | View |
2021-05-14 Purchase | 2021-05-18 5:00 pm | SOLIGENIX INC. | SNGX | ZELDIS JEROME B Director | 3,000 | $0.888 | $2,664 | 22,917 (Direct) | View |
2021-05-14 Sale | 2021-05-18 5:00 pm | SOLIGENIX INC. | SNGX | ZELDIS JEROME B Director | 3,000 | $0.9002 | $2,701 | 22,917 (Direct) | View |
2021-02-17 Purchase | 2021-02-19 4:30 pm | NexImmune Inc. | NEXI | ZELDIS JEROME B Executive VP of Research & Dev | 5,882 | $17 | $99,994 | 5,882 (Direct) | View |
2020-05-28 Purchase | 2020-05-28 10:58 am | BioSig Technologies Inc. | BSGM | ZELDIS JEROME B Director | 1,000 | $10.49 | $10,489 | 107,944 (Direct) | View |
2019-11-19 Purchase | 2019-11-19 4:19 pm | SOLIGENIX INC. | SNGX | ZELDIS JEROME B Director | 2,000 | $0.925 | $1,850 | 22,917 (Direct) | View |
2019-09-19 Purchase | 2019-09-23 4:19 pm | SOLIGENIX INC. | SNGX | ZELDIS JEROME B Director | 4,000 | $0.935 | $3,740 | 20,917 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
2024-02-15 Option Award | 2024-02-16 4:10 pm | N/A 2034-02-14 | PTC THERAPEUTICS INC. | PTCT | ZELDIS JEROME B Director | 14,000 | $0 | 24,500 (Direct) | View |
2023-12-15 Option Award | 2023-12-15 4:10 pm | N/A 2033-12-14 | SOLIGENIX INC. | SNGX | ZELDIS JEROME B Director | 38,136 | $0 | 38,136 (Direct) | View |
2023-08-17 Option Award | 2023-08-21 4:34 pm | 2023-08-17 2033-08-17 | NEXGEL INC. | NXGL | ZELDIS JEROME B Director | 15,000 | $0 | 15,000 (Direct) | View |
2023-01-05 Option Award | 2023-01-09 4:16 pm | N/A 2033-01-04 | PTC THERAPEUTICS INC. | PTCT | ZELDIS JEROME B Director | 14,000 | $0 | 20,500 (Direct) | View |
2022-11-17 Option Award | 2022-11-21 4:33 pm | N/A 2032-11-16 | SOLIGENIX INC. | SNGX | ZELDIS JEROME B Director | 46,154 | $0 | 145,285 (Direct) | View |
2022-04-05 Option Award | 2022-04-07 7:12 pm | N/A 2032-04-04 | NexImmune Inc. | NEXI | ZELDIS JEROME B Executive VP of Research & Dev | 80,100 | $0 | 80,100 (Direct) | View |
2022-01-07 Option Award | 2022-01-11 4:10 pm | N/A 2032-01-06 | PTC THERAPEUTICS INC. | PTCT | ZELDIS JEROME B Director | 15,200 | $0 | 18,500 (Direct) | View |
2021-12-27 Option Award | 2022-01-03 4:46 pm | 2021-12-27 2026-12-26 | NEXGEL INC. | NXGL | ZELDIS JEROME B Director | 9,091 | $0.01 | 91,819 (Direct) | View |
2021-09-23 Option Award | 2021-09-24 4:12 pm | N/A 2031-09-22 | SOLIGENIX INC. | SNGX | ZELDIS JEROME B Director | 29,126 | $0 | 29,126 (Direct) | View |
2021-03-08 Option Award | 2021-03-12 4:39 pm | 2021-03-08 2031-03-08 | NEXGEL INC. | ZELDIS JEROME B Director | 666,667 | $0 | 3,166,667 (Direct) | View | |
2021-02-11 Option Award | 2021-02-16 2:57 pm | N/A 2025-02-11 | NexImmune Inc. | NEXI | ZELDIS JEROME B Executive VP of Research & Dev | 351,016 | $0 | 351,016 (Direct) | View |
2021-01-06 Option Award | 2021-01-08 5:07 pm | N/A 2031-01-05 | PTC THERAPEUTICS INC. | PTCT | ZELDIS JEROME B Director | 11,650 | $0 | 13,300 (Direct) | View |
2020-09-16 Option Award | 2020-09-18 4:36 pm | N/A 2030-09-15 | SOLIGENIX INC. | SNGX | ZELDIS JEROME B Director | 15,228 | $0 | 15,228 (Direct) | View |
2020-07-14 Option Award | 2020-07-15 8:10 pm | N/A N/A | BioSig Technologies Inc. | BSGM | ZELDIS JEROME B Director | 50,000 | $0 | 50,000 (Direct) | View |
2020-04-14 Option Award | 2020-04-16 11:50 am | N/A 2030-04-14 | BioSig Technologies Inc. | BSGM | ZELDIS JEROME B Director | 50,000 | $0 | 50,000 (Direct) | View |
2020-01-29 Option Award | 2020-01-31 4:44 pm | N/A 2030-01-28 | PTC THERAPEUTICS INC. | PTCT | ZELDIS JEROME B Director | 11,650 | $0 | 11,650 (Direct) | View |
2019-10-30 Option Award | 2019-10-31 2:59 pm | N/A 2029-10-30 | BioSig Technologies Inc. | BSGM | ZELDIS JEROME B Director | 29,000 | $0 | 29,000 (Direct) | View |
2019-09-06 Option Award | 2019-09-10 6:41 pm | N/A 2029-09-05 | SOLIGENIX INC. | SNGX | ZELDIS JEROME B Director | 30,928 | $0 | 30,928 (Direct) | View |
2019-05-21 Conversion | 2019-05-22 5:02 pm | N/A N/A | BioSig Technologies Inc. | BSGM | ZELDIS JEROME B Director | 50 | $0 | 106,944 (Direct) | View |
2019-05-22 Exercise | 2019-05-22 5:02 pm | N/A N/A | BioSig Technologies Inc. | BSGM | ZELDIS JEROME B Director | 20,000 | $3.4 | 106,944 (Direct) | View |
2019-05-22 Exercise | 2019-05-22 5:02 pm | N/A N/A | BioSig Technologies Inc. | BSGM | ZELDIS JEROME B Director | 1,097 | $6.85 | 106,944 (Direct) | View |
2019-05-21 Option Award | 2019-05-22 5:02 pm | N/A N/A | BioSig Technologies Inc. | BSGM | ZELDIS JEROME B Director | 3,804 | $7.44 | 106,944 (Direct) | View |
2019-05-22 Exercise | 2019-05-22 5:02 pm | 2016-12-22 2026-12-22 | BioSig Technologies Inc. | BSGM | ZELDIS JEROME B Director | 21,097 | $0 | 106,944 (Direct) | View |
2019-05-21 Conversion | 2019-05-22 5:02 pm | N/A N/A | BioSig Technologies Inc. | BSGM | ZELDIS JEROME B Director | 13,334 | $3.75 | 106,944 (Direct) | View |
Ownership | 2019-05-22 12:55 pm | N/A N/A | BioSig Technologies Inc. | BSGM | ZELDIS JEROME B Director | 0 | $0 | 243,140 (Direct) | View |